Cargando…
Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential
Allogeneic hematopoietic stem cell transplantation is the main curative therapy for many hematologic malignancies. Its potential relies on graft-versus-tumor effects which associate with graft-versus-host disease. Mesenchymal stromal cells (MSCs) possess immunomodulatory properties that make them at...
Autores principales: | Auletta, Jeffery J., Zale, Elizabeth A., Welter, Jean F., Solchaga, Luis A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062108/ https://www.ncbi.nlm.nih.gov/pubmed/21437189 http://dx.doi.org/10.4061/2011/235176 |
Ejemplares similares
-
Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation
por: Wang, Fangjing, et al.
Publicado: (2015) -
The immunosuppressive capacity of human mesenchymal stromal cells derived from amnion and bone marrow
por: Meesuk, Ladda, et al.
Publicado: (2016) -
Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties
por: Neo, Shu Hui, et al.
Publicado: (2023) -
Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells
por: Jakl, Viktoria, et al.
Publicado: (2023) -
Assessing Adipogenic Potential of Mesenchymal Stem Cells: A Rapid Three-Dimensional Culture Screening Technique
por: Welter, Jean F., et al.
Publicado: (2013)